PROCEPT BioRobotics (PRCT) Revenue (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Revenue data on file, last reported at $83.1 million in Q1 2026.

• Quarterly Revenue rose 20.2% year-over-year to $83.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $322.0 million (up 29.26% YoY) and the FY2025 annual result came in at $308.1 million, up 37.22% from the prior year.
• Revenue climbed to $83.1 million in Q1 2026 per PRCT's latest filing, from $76.4 million in the prior quarter.
• Across five years, Revenue topped out at $83.3 million in Q3 2025 and bottomed at $14.2 million in Q1 2022.
• The 5-year median for Revenue is $44.5 million (2024), against an average of $48.6 million.
• The widest annual swing landed in 2022, when Revenue jumped 134.76%; it then grew 11.94% in 2025.
• Tracing PRCT's Revenue over 5 years: stood at $23.8 million in 2022, then soared by 83.29% to $43.6 million in 2023, then surged by 56.57% to $68.2 million in 2024, then gained by 11.94% to $76.4 million in 2025, then climbed by 8.84% to $83.1 million in 2026.
• Per Business Quant, the three latest PRCT Revenue figures stand at $83.1 million (Q1 2026), $76.4 million (Q4 2025), and $83.3 million (Q3 2025).

Peer Comparison